Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Qinghai Jiumei Tibetan Hospital is a prominent healthcare and pharmaceutical institution based in Xining, China, specializing in Traditional Tibetan Medicine (Sowa Rigpa). Founded by the renowned physician Jiumei Pengcuo, the organization integrates clinical services with a large-scale GMP-certified manufacturing operation for traditional Tibetan pharmaceuticals. The hospital produces a wide array of proprietary medicines, including the well-known 25-flavor Turquoise Pill and 7-flavor Pearl Pill, which target chronic conditions such as liver disease, cardiovascular disorders, and neurological ailments. As a key player in the modernization of ethnic medicine, Qinghai Jiumei combines ancient healing traditions with contemporary quality control and research standards. The institution serves as a major center for Tibetan medical treatment, education, and drug production in the Qinghai-Tibet Plateau region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Qinghai Jiumei Tibetan Hospital.